Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
Cuscino in Lana Merino
Trapunta Ivernale Merino
Λευκά ειδη - € 150,00 - Vendora
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text
BIANCO DAY – Επώνυμα λευκά είδη
Challenges and Opportunities in Cancer Drug Resistance | Chemical Reviews
Λευκά Είδη Επώνυμα Σε Προσφορές | KENTIA
BIANCO DAY – Επώνυμα λευκά είδη
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text
Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text
Παπλώματα σε Προσφορά - Οικονομικά και Επώνυμα έως 50% - Homee
Challenges and Opportunities in Cancer Drug Resistance | Chemical Reviews
Παπλώματα
Challenges and Opportunities in Cancer Drug Resistance | Chemical Reviews
BIANCO DAY – Επώνυμα λευκά είδη
Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library
BIANCO DAY – Επώνυμα λευκά είδη
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library
The crossroads of breast cancer progression: insights into the modulat | OTT
BIANCO DAY – Επώνυμα λευκά είδη
Cancers | Free Full-Text | Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs
